Extensive Demand for T-Cell Adoptive Immunotherapy Rising with Growing Prevalence of Cancer
Share this article Share this article PALM BEACH, Fla., Feb. 23, 2021 /PRNewswire/ -- In the breast cancer therapy market, the rise in the prevalence of cancer, has propelled the T-cell therapy market over the last few years and it is projected to continue to do so for several years to come. T-cell therapy includes using genetically engineered T-cells to produce an artificial T-cell receptor for applications in immunotherapy. Growing prevalence of cancer across the world and increase in cancer research & development drive the market. According to the WHO, the number of global cancer death...